Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: HIV Ther. 2010 May;4(3):371–379. doi: 10.2217/hiv.10.23

Figure 1. Distribution of neurocognitive diagnoses according to Frascati, asymptomatic neurocognitive impairment and Memorial Sloan Kettering ratings.

Figure 1

MSK ratings are defined as follows: MSK 0.5: equivocal/subclinical cognitive impairment; MSK 1: mild dementia; MSK 2: moderate dementia. AAN: American Academy of Neurology; ANI: Asymptomatic neurocognitive impairment; HAD: HIV-associated dementia; MCMD: Minor cognitive motor disorder; MND: Mild neurocognitive disorder; MSK: Memorial Sloan Kettering.